EGFR-Driven Behavior and Intrapatient T790M Mutation Heterogeneity of Non-Small-Cell Carcinoma With Squamous Histology

被引：11
作者：
Graziano, Paolo [1 ]
de Marinis, Filippo [1 ]
Gori, Bruno [1 ]
Gasbarra, Rita [1 ]
Migliorino, Rita [1 ]
De Santis, Stefano [1 ]
Pelosi, Giuseppe [2 ,3 ]
Leone, Alvaro [1 ]
机构：
[1] San Camillo Forlanini Hosp, Rome, Italy
[2] Fdn Ist Ricovero & Cura Carattere Sci, Ist Tumori, Milan, Italy
[3] Univ Milan, Milan, Italy
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2015年 / 33卷 / 31期
关键词：
LUNG-CANCER; GEFITINIB; ERLOTINIB; PATIENT;
D O I：
10.1200/JCO.2013.49.5697
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：E115 / E118
页数：4
相关论文
共 12 条
[1]   EGFR Mutations in Squamous Cell Lung Cancer in Never-Smokers [J].
Baik, Christina S. ;
Pritchard, Colin C. ;
Eaton, Keith D. ;
Chow, Laura Q. .
JOURNAL OF THORACIC ONCOLOGY, 2013, 8 (01) :E6-E7
[2]   Treatment of advanced non-small-cell lung cancer: Italian Association of Thoracic Oncology (AIOT) clinical practice guidelines [J].
de Marinis, Filippo ;
Rossi, Antonio ;
Di Maio, Massimo ;
Ricciardi, Serena ;
Gridelli, Cesare .
LUNG CANCER, 2011, 73 (01) :1-10
[3]   Oncogenic activity of epidermal growth factor receptor kinase mutant alleles is enhanced by the T790M drug resistance mutation [J].
Godin-Heymann, Nadia ;
Bryant, Ianthe ;
Rivera, Miguel N. ;
Ulkus, Lindsey ;
Bell, Daphne W. ;
Riese, David J. ;
Settleman, Jeffrey ;
Haber, Daniel A. .
CANCER RESEARCH, 2007, 67 (15) :7319-7326
[4]   How Sensitive Are Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors for Squamous Cell Carcinoma of the Lung Harboring EGFR Gene-Sensitive Mutations? [J].
Hata, Akito ;
Katakami, Nobuyuki ;
Yoshioka, Hiroshige ;
Kunimasa, Kei ;
Fujita, Shiro ;
Kaji, Reiko ;
Notohara, Kenji ;
Imai, Yukihiro ;
Tachikawa, Ryo ;
Tomii, Keisuke ;
Korogi, Yohei ;
Iwasaku, Masahiro ;
Nishiyama, Akihiro ;
Ishida, Tadashi .
JOURNAL OF THORACIC ONCOLOGY, 2013, 8 (01) :89-95
[5]   The Long-term Survival of a Patient with Adenosquamous Lung Carcinoma Harboring EGFR-activating Mutations Who was Treated with Gefitinib [J].
Iwanaga, Kentaro ;
Sueoka-Aragane, Naoko ;
Nakamura, Tomomi ;
Mori, Daisuke ;
Kimura, Shinya .
INTERNAL MEDICINE, 2012, 51 (19) :2771-2774
[6]   Significance of epidermal growth factor receptor gene mutations in squamous cell lung carcinoma [J].
Miyamae, Yohei ;
Shimizu, Kimihiro ;
Hirato, Junko ;
Araki, Takuya ;
Tanaka, Kazumi ;
Ogawa, Hiroomi ;
Kakegawa, Seiichi ;
Sugano, Masayuki ;
Nakano, Tetsuhiro ;
Mitani, Yasumasa ;
Kaira, Kyoichi ;
Takeyoshi, Izumi .
ONCOLOGY REPORTS, 2011, 25 (04) :921-928
[7]   Response to Erlotinib in Patients with EGFR Mutant Advanced Non-Small Cell Lung Cancers with a Squamous or Squamous-like Component [J].
Paik, Paul K. ;
Varghese, Anna M. ;
Sima, Camelia S. ;
Moreira, Andre L. ;
Ladanyi, Marc ;
Kris, Mark G. ;
Rekhtman, Natasha .
MOLECULAR CANCER THERAPEUTICS, 2012, 11 (11) :2535-2540
[8]   ΔNp63 (p40) and Thyroid Transcription Factor-1 Immunoreactivity on Small Biopsies or Cellblocks for Typing Non-small Cell Lung Cancer A Novel Two-Hit, Sparing-Material Approach [J].
Pelosi, Giuseppe ;
Fabbri, Alessandra ;
Bianchi, Fabrizio ;
Maisonneuve, Patrick ;
Rossi, Giulio ;
Barbareschi, Mattia ;
Graziano, Paolo ;
Cavazza, Alberto ;
Rekhtman, Natasha ;
Pastorino, Ugo ;
Scanagatta, Paolo ;
Papotti, Mauro .
JOURNAL OF THORACIC ONCOLOGY, 2012, 7 (02) :281-290
[9]   Squamous Cell Carcinoma of the Lung: Molecular Subtypes and Therapeutic Opportunities [J].
Perez-Moreno, Pablo ;
Brambilla, Elisabeth ;
Thomas, Roman ;
Soria, Jean-Charles .
CLINICAL CANCER RESEARCH, 2012, 18 (09) :2443-2451
[10]   Clarifying the Spectrum of Driver Oncogene Mutations in Biomarker-Verified Squamous Carcinoma of Lung: Lack of EGFR/KRAS and Presence of PIK3CA/AKT1 Mutations [J].
Rekhtman, Natasha ;
Paik, Paul K. ;
Arcila, Maria E. ;
Tafe, Laura J. ;
Oxnard, Geoffrey R. ;
Moreira, Andre L. ;
Travis, William D. ;
Zakowski, Maureen F. ;
Kris, Mark G. ;
Ladanyi, Marc .
CLINICAL CANCER RESEARCH, 2012, 18 (04) :1167-1176
12